---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
sourceUrl: https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "Qq36FhLvkE2djGUExrEdDkNa1CtTYPU1YA+6KGXMlOYv3pz5cN/B9/CslHnehrf2OPh9U/csF9eOYdjgOmLguhShKqX/1oPKwRLkaweEc5EbH/idjkWXojKJDVlRu2FKc5osYe3s7mNBVf9ZOO47nTUUvZJeS+w4WjCsj5/FAQUufUeM1+LSutPr0yQ6SaP7/u87szjTjws+kJ4EEDHnLlA0v4isk1On2a/yaeM8vBiIdBXSoUBjzDeCw/Du9Arcuk5rSudLK6TuBZHaZAHOSsYAXRfVs+73xXeO0gsl2zIjhch2O+AlFtQ8svZFvTID;z+eHw4L6t5uwSsX0xyYJbg=="
---

